Inhibition of protein synthesis by didemnins: cell potency and SAR

J Med Chem. 2000 Nov 2;43(22):4212-8. doi: 10.1021/jm000168v.

Abstract

Synthetic and naturally occurring didemnins are potent and specific inhibitors of protein synthesis in vitro. Structure-activity analysis indicates a requirement for the intact macrocycle; however, the smaller ring size represented by the didemnin analogue, tamandarin A, is equipotent to didemnin B. Replacement of the N,O-dimethyltyrosine by a N-methylphenylalanine or N-methylleucine residue is also well-tolerated. The rank order for inhibition of protein synthesis in vitro appears to be retained in MCF-7 cells, albeit at much higher potency. This increase in potency is explained for the first time by data indicating that MCF-7 cells can accumulate didemnin B up to 2-3 orders of magnitude compared to the growth medium.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cell-Free System
  • Depsipeptides*
  • Humans
  • Peptide Elongation Factor 1 / antagonists & inhibitors
  • Peptides, Cyclic / chemistry
  • Peptides, Cyclic / metabolism
  • Peptides, Cyclic / pharmacology*
  • Protein Synthesis Inhibitors / chemistry
  • Protein Synthesis Inhibitors / pharmacology*
  • Rabbits
  • Structure-Activity Relationship

Substances

  • Depsipeptides
  • Peptide Elongation Factor 1
  • Peptides, Cyclic
  • Protein Synthesis Inhibitors
  • didemnins